Applicant, as named in the Orange Book

Mundipharma

Next listed expiry: Rezzayo on 14 Jul 2038. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Rezzayo rezafungin acetate	rezafungin acetate	217417	14 Jul 2038	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.